Literature DB >> 2593184

Free radicals mediate peroxidative damage in guinea pig hippocampus in vitro.

T C Pellmar1, K L Neel, K H Lee.   

Abstract

Previous studies have shown that peroxide caused electrophysiological damage. The present study investigates the action of agents that interfere with a free radical process in an effort to define the mechanism of peroxide damage. Deferoxamine chelates iron, making it unavailable for the Fenton reaction and thereby preventing the formation of hydroxyl free radicals from peroxide. Dimethylsulfoxide (DMSO) scavenges hydroxyl free radicals. Trolox-C, a water soluble Vitamin E analog, is an antioxidant that can scavenge peroxy radicals. Slices of hippocampus were removed from brains of euthanized guinea pigs. Electrical stimulation of an orthodromic pathway to CA1 region evoked a synaptic response and a population spike. Input-output curves were generated to evaluate the protection by deferoxamine, Trolox-C, and DMSO on the synaptic damage and impaired spike generation caused by peroxide. Lipid peroxidation was measured by the thiobarbituric acid test. Peroxide was found to increase lipid peroxidation. Deferoxamine and Trolox-C protected against the peroxide-induced synaptic damage, impaired spike generation, and lipid peroxidation. DMSO was ineffective synaptically but reduced peroxide damage to spike generating mechanisms and further lipid peroxidation. The data support the hypothesis that peroxide causes damage through a free radical mechanism.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2593184     DOI: 10.1002/jnr.490240314

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  11 in total

1.  Protective Effects of Chlorogenic Acid and its Metabolites on Hydrogen Peroxide-Induced Alterations in Rat Brain Slices: A Comparative Study with Resveratrol.

Authors:  Zulfiye Gul; Celaleddin Demircan; Deniz Bagdas; Rifat Levent Buyukuysal
Journal:  Neurochem Res       Date:  2016-05-09       Impact factor: 3.996

2.  Release of endogenous glutamate, aspartate, GABA, and taurine from hippocampal slices from adult and developing mice under cell-damaging conditions.

Authors:  P Saransaari; S S Oja
Journal:  Neurochem Res       Date:  1998-04       Impact factor: 3.996

3.  Beta-alanine release from the adult and developing hippocampus is enhanced by ionotropic glutamate receptor agonists and cell-damaging conditions.

Authors:  P Saransaari; S S Oja
Journal:  Neurochem Res       Date:  1999-03       Impact factor: 3.996

4.  Optical imaging reveals elevated intracellular chloride in hippocampal pyramidal neurons after oxidative stress.

Authors:  R Sah; R D Schwartz-Bloom
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

5.  Mechanisms of D-aspartate release under ischemic conditions in mouse hippocampal slices.

Authors:  P Saransaari; S S Oja
Journal:  Neurochem Res       Date:  1999-08       Impact factor: 3.996

6.  NMDA excitotoxicity and free radical generation in rat brain homogenates: application of a chemiluminescence assay.

Authors:  B Küçükkaya; G Haklar; A S Yalçin
Journal:  Neurochem Res       Date:  1996-12       Impact factor: 3.996

7.  Characteristics of GABA release induced by free radicals in mouse hippocampal slices.

Authors:  Pirjo Saransaari; Simo S Oja
Journal:  Neurochem Res       Date:  2007-08-22       Impact factor: 3.996

8.  Enhanced release of adenosine under cell-damaging conditions in the developing and adult mouse hippocampus.

Authors:  Pirjo Saransaari; Simo S Oja
Journal:  Neurochem Res       Date:  2003-09       Impact factor: 3.996

Review 9.  Possible actions of cannabidiol in obsessive-compulsive disorder by targeting the WNT/β-catenin pathway.

Authors:  Alexandre Vallée; Yves Lecarpentier; Jean-Noël Vallée
Journal:  Mol Psychiatry       Date:  2021-04-09       Impact factor: 15.992

Review 10.  Lithium: a potential therapeutic strategy in obsessive-compulsive disorder by targeting the canonical WNT/β pathway.

Authors:  Alexandre Vallée; Jean-Noël Vallée; Yves Lecarpentier
Journal:  Transl Psychiatry       Date:  2021-04-07       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.